![](/img/cover-not-exists.png)
Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer
Gharaibeh, Mahdi, McBride, Ali, Bootman, J. Lyle, Patel, Hitendra, Abraham, IvoVolume:
20
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2016.1269015
Date:
April, 2017
File:
PDF, 1.03 MB
english, 2017